Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 490 | 540 | 754 | 759 | 819 |
| Income taxes - deferred | N/A | -6 | 0 | N/A | N/A |
| Accounts receivable | -22 | 1,384 | 107 | 69 | 2,058 |
| Other Working Capital | 586 | 3,943 | 3,178 | -1,535 | 659 |
| Other Operating Activity | -4,105 | -6,029 | -6,926 | -6,705 | -9,138 |
| Operating Cash Flow | $-3,051 | $-168 | $-2,887 | $-7,412 | $-5,602 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | 0 | 7 | 0 |
| Other Investing Activity | -25 | 5,705 | -316 | -94 | -144 |
| Investing Cash Flow | $-25 | $5,705 | $-316 | $-87 | $-144 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,165 | -538 | -277 | -71 | -62 |
| Other Financing Activity | 246 | 139 | 134 | 1,423 | 48 |
| Financing Cash Flow | $-919 | $-399 | $-143 | $1,352 | $-14 |
| Exchange Rate Effect | 0 | -447 | 808 | -134 | -77 |
| Beginning Cash Position | 24,145 | 19,454 | 21,992 | 28,273 | 34,110 |
| End Cash Position | 20,150 | 24,145 | 19,454 | 21,992 | 28,273 |
| Net Cash Flow | $-3,995 | $5,138 | $-3,346 | $-6,147 | $-5,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,051 | -168 | -2,887 | -7,412 | -5,602 |
| Capital Expenditure | -25 | -309 | -316 | -94 | -144 |
| Free Cash Flow | -3,076 | -477 | -3,203 | -7,506 | -5,746 |